An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis

NCT05399368 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

229

Enrollment

INDUSTRY

Sponsor class

Stopped Study on clinical hold by FDA

Conditions

Atopic Dermatitis

Interventions

DRUG: RPT193
OTHER: Placebo

Sponsor

RAPT Therapeutics, Inc.